Letizia Penolazzi

Letizia Penolazzi

Auto-generated profile, based on publicly available information

Letizia Penolazzi

Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2008 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
LPLetizia Penolazzi
Letizia Penolazzi
Ilaria LamprontiIlaria Lampronti
Ilaria Lampronti
Monica BorgattiMonica Borgatti
Monica Borgatti
MKMahmud Tareq Hassan Khan
Mahmud Tareq Hassan Khan
MZMargherita Zennaro
Margherita Zennaro
Roberto GAMBARIRoberto GAMBARI
Roberto GAMBARI
Osteoclasts (OCs) are involved in rheumatoid arthritis and in several pathologies associated with bone loss. Recent results support the concept that some medicinal plants and derived natural products are of great interest for developing therapeutic strategies against bone disorders, including rheumatoid arthritis and osteoporosis. In this study we determined whether extracts of Emblica officinalis fruits display activity of possible interest for the treatment of rheumatoid arthritis and osteoporosis by activating programmed cell death of human primary osteoclasts.

17 February 2021 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
ELElisabetta Lambertini
Elisabetta Lambertini
LPLetizia Penolazzi
Letizia Penolazzi
APAssunta Pandolfi
Assunta Pandolfi
DMDomitilla Mandatori
Domitilla Mandatori
VSVincenzo Sollazzo
Vincenzo Sollazzo
RPRoberta Piva
Roberta Piva
Glucosamine (GlcN) functions as a building block of the cartilage matrix, and its multifaceted roles in promoting joint health have been extensively investigated. However, the role of GlcN in osteogenesis and bone tissue is poorly understood, mainly due to the lack of adequate experimental models. As a result, the benefit of GlcN application in bone disorders remains controversial. In order to further elucidate the pharmacological relevance and potential therapeutic/nutraceutic efficacy of GlcN, the effect of GlcN treatment was investigated in human primary osteoclasts (hOCs) and osteoblasts (hOBs) that were cultured with two‑dimensional (2D) traditional methods or co‑cultured in a 3D dynamic system more closely resembling the in vivo bone microenvironment. Under these conditions, osteoclastogenesis was supported by hOBs and sizeable self‑assembling aggregates were obtained. The differentiated hOCs were evaluated using tartrate‑resistant acid phosphatase assays and osteogenic differentiation was monitored by analyzing mineral matrix deposition via Alizarin Red staining, with expression of specific osteogenic markers determined via reverse transcription‑quantitative PCR. It was found that crystalline GlcN sulfate was effective in decreasing osteoclastic cell differentiation and function. hOCs isolated from patients with OA were more sensitive compared with those from healthy donors. Additionally, GlcN exhibited anabolic effects on hOCs both in 2D conventional cell culture and in hOC/hOB 3D dynamic co‑culture. The present study demonstrated for the first time the effectiveness of a 3D dynamic co‑culture system for characterizing the spectrum of action of GlcN on the bone microenvironment, which may pave the way for more fully determining the potential applications of a compound such as GlcN, which is positioned between pharmaceuticals and nutraceuticals. Based on the present findings, it is hypothesized that GlcN may have potential benefits in the treatment of osteopenic diseases such as osteoporosis, as well as in bone maintenance.

3 February 2024 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
LPLetizia Penolazzi
Letizia Penolazzi
ACAnna Chierici
Anna Chierici
MNMaria Pina Notarangelo
Maria Pina Notarangelo
BDBeatrice Dallan
Beatrice Dallan
GLGina Lisignoli
Gina Lisignoli
CNClaudio Nastruzzi
Claudio Nastruzzi

7 January 2025 in Calcified Tissue International
Verified
Journal Article
Closed access
PDF file
EMElena Della Morte
Elena Della Morte
MNMaria Pina Notarangelo
Maria Pina Notarangelo
SNStefania Niada
Stefania Niada
CGChiara Giannasi
Chiara Giannasi
FFFederica Fortuna
Federica Fortuna
LPLetizia Penolazzi
Letizia Penolazzi

3 February 2026 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Open access
ACAnna Chierici
Anna Chierici
GDGiovanni D’ATri
Giovanni D’ATri
CMCristina Manferdini
Cristina Manferdini
ELElisabetta Lambertini
Elisabetta Lambertini
GLGina Lisignoli
Gina Lisignoli
LPLetizia Penolazzi
Letizia Penolazzi
Bioinspired scaffolds, designed to mimic natural tissue and provide biological cues for tissue regeneration, are becoming increasingly important in the field of tissue engineering. We previously developed hydrogel scaffolds based on alginate and decellularized Wharton's jelly (DWJ) from an umbilical cord. These scaffolds have proven to be highly effective in promoting the recovery of the lost discogenic phenotype in degenerated intervertebral disc (IVD) cells obtained from patients undergoing discectomy. This prompted us to refine the various steps of the protocol to optimize the development of stable DWJ-based scaffolds with anatomically shaped geometries such as millimeter-scale cylinders (millicylinders) suitable for use in articular cartilage tissue engineering. Particular attention was paid to the handling of the materials used, the reproducibility of data, and the adaptability of the developed system to different experimental needs/conditions, including the transmission of mechanical stimuli and the evaluation of the reactivity of the combined cells. Here, we report the characterization of both the physicochemical properties of the hydrogel produced and its specific biological effects by using IVD cells and macrophages as experimental models. The detailed description of the various steps provides a protocol that aims to facilitate the development of DWJ-based hydrogels that may provide new strategies for addressing joint degeneration.

25 November 2025 in Histochemistry and Cell Biology
Verified
Journal Article
Open access
PDF file
LPLetizia Penolazzi
Letizia Penolazzi
CAChiara Angelini
Chiara Angelini
RNRiccardo Nadalini
Riccardo Nadalini
ACAnna Chierici
Anna Chierici
ELElisabetta Lambertini
Elisabetta Lambertini
RPRoberta Piva
Roberta Piva
Intervertebral disc degeneration (IDD) is known as a primary contributor to low back pain, a debilitating condition which is the leading cause of disability worldwide. Traditionally, its assessment is based on clinical parameters, including magnetic resonance imaging (MRI). However, patients with similar radiological findings may have significantly different prognoses suggesting the involvement of patient-specific biomarkers and little-investigated molecules supporting the complexity of the pathophysiological microenvironment of the intervertebral disc (IVD). We conducted a study on IVD biopsies from 40 patients with mild IDD (Pfirrmann III), to identify a potential molecular signature that correlates with clinical and behavioral parameters including sex, age, smoking, body mass index (BMI), duration of symptoms prior to surgery, inflammatory cell density, or surgical site. Immunohistological analysis focused on the expression of proteins involved in the defense against oxidative stress, in the maintenance of IVD homeostasis, and energy metabolism: the transcription factors FOXO3a, HIF1α, Bry, the enzyme SOD2, and the glucose transporter GLUT1. Significant differences in protein expression were observed only in relation to Pfirrmann grade. Within the grade III subgroup, expression levels did not vary with patient-specific parameters or clinical outcomes such as complete healing, recurrence, or persistent pain after surgery. This highlights the importance of broadening the scope of assessment in pathological conditions such as IDD. Rather than limiting the evaluation to the expression level of a single protein marker, it is crucial to collect comprehensive data on the various factors that may influence individual patient responses to disc degeneration.